Depression Work Group for the 2016 Clinical Guidelines for the Management of Adults with MDD

Transcription

1 Name Academic Affiliation COI Disclosures Lynda G. Balneaves Venkat Bhat MD Pierre Blier Daniel Blumberger MD, MSc, FRCPC Zafiris J. (Jeff) Daskalakis Jonathan Downar Murray W. Enns Guy Faulkner Benicio N. Frey MD, MSc,, FRCPC University of Ottawa University of Manitoba School of Kinesiology, Department of Psychiatry and Behavioural Neurosciences, McMaster University Research grants, personal fees, and/or nonfinancial support from AstraZeneca, Bristol Myers Squibb, Eli Lilly, Forest, Euthymics, Janssen, Lundbeck, Merck, Otsuka, Pfizer, Pierre Fabre, Servier, Shire, Takeda, and Valeant Research funds/support from Brain Canada, Brain Research and Development Ltd., Brainsway Inc., CAMH Foundation, Campbell Institute, Canadian Institutes of Health Research, National Institutes of Health, Tonika/Magventure, and Invidior received research funds from Brain and Behavior Research Foundation, Brainsway Inc., CAMH Foundation, Campbell Institute, Canadian Institutes of Health Research, Eli Lilly, Hoffmann-La Roche Limited, Merck, Ontario Mental Health Foundation, and Sunovion Research support or honoraria from ANT Neuro, Canadian Institutes of Health Research, Brain Canada, Edgestone Foundation, Klarman Family Foundation, Lundbeck, MagVenture, National Institutes of Health, and Toronto General and Western Hospital Foundation Honoraria for ad hoc speaking or advising/ consulting or received research funds from Alternative Funding Plan Innovations Award, AstraZeneca, Brain & Behavioral Foundation, Bristol-Myers Squibb, Canadian Institutes of Health Research, Canadian Network for Mood and Anxiety Treatments, Canadian Psychiatric Association, Daiichi Sankyo, Eli Lilly, Hamilton Health Sciences Foundation, J. P. Bickell Foundation, Lundbeck, Lundbeck International Neuroscience Foundation, Ontario Brain Institute, OMHF, Ontario Ministry of Research and Innovation, NSERC, Pfizer, Servier, Society for Women s Health Research, Sunovion, and the Teresa Cascioli Charitable Foundation

2 Peter Giacobbe MD, MSc, FRCPC Sophie Grigoriadis Mehrul Hasnain Zahinoor Ismail Natalia Jaworska Fabrice Jollant MD, Sidney H. Kennedy Theo Kolivakis Memorial University of Newfoundland University of Calgary Speaker and consultant honoraria or research funds from Brain & Behavior Research Foundation, Bristol-Myers Squibb, Canadian Institutes of Health Research, Lundbeck, National Institute of Health, and St. Jude Medical Honoraria as a consultant, member of an advisory committee, or for lectures from Actavis, Bristol Myers Squibb, Eli Lilly Canada, and Pfizer, as well as research grant support from Canadian Institutes of Health Research, CR Younger Foundation, Ontario Mental Health Foundation, and Ontario Ministry of Health and Long-Term Care received research funds from Canadian Biomarker Integration Network for Depression, Canadian Consortium for Neurodegeneration and Aging, Canadian Institutes of Health Research, Janssen, Joan and Clifford Hatch Foundation, Katthy Taylor Chair in Vascular Dementia, Lundbeck, National Institute of Aging, Ontario AFP Innovation Fund, Otsuka, Pfizer, and Sunovion research funds from Allergan, Brain Canada, Bristol-Myers Squibb, Canadian Institutes of Health Research, Janssen, Lundbeck, Ontario Brain Institute, Pfizer, St. Jude Medical, Servier, and Sunovion Speaker and/or advisory honoraria from Astra-Zeneca, Bristol- Myers Squibb, Eli Lilly Canada, Lundbeck, Lundbeck-Otsuka, Janssen-Ortho, Pfizer, and Sunovion

3 Raymond W. Lam Honoraria for ad hoc speaking or advising/ consulting or received research funds from Asia-Pacific Economic Cooperation, AstraZeneca, Brain Canada, Bristol-Myers Squibb, Canadian Institutes of Health Research, Canadian Depression Research and Intervention Network, Canadian Network for Mood and Anxiety Treatments, Canadian Psychiatric Association, Coast Capital Savings, Johnson & Johnson, Lundbeck, Lundbeck Institute, Medscape, Pfizer, St. Jude Medical, Takeda, University Health Network Foundation, and Vancouver Coastal Health Research Institute Anthony J. Levitt Research grants, personal fees, and/or nonfinancial support from Eli Lilly, Janssen, Lundbeck, and Sanofi-Aventis Glenda M. MacQueen Shane J. McInerney MD Diane McIntosh Roger S. McIntyre Erin E. Michalak Roumen V. Milev Mandana Modirrousta University of Calgary Queen s University University of Manitoba Honoraria for advisory board or speaker for Janssen, Lilly, Lundbeck, and Pfizer Fellowship funding from Pfizer received research funds from Allergan, Bristol-Myers Squibb, Lundbeck, Janssen-Ortho, Otsuka, Pfizer, Shire, and Sunovion Research grants and/or personal fees and/or nonfinancial support from AstraZeneca, Bristol Myers Squibb, CME Outfitters, Eli Lilly, France Foundation, GlaxoSmithKline, I3CME, Janssen-Ortho, Lundbeck, Merck, National Alliance for Research on Schizophrenia and Depression, National Institutes of Mental Health, Optum Health, Organon, Pfizer, Physicians Postgraduate Press, Shire, and Stanley Medical Research Institute Advisory honoraria from Lundbeck Speaker and consultant honoraria or research funds from Allergan, Bristol-Myers Squibb, Canadian Institutes of Health Research, Canadian Network for Mood and Anxiety Treatments, Canadian Psychiatric Association, Eli Lilly, Johnson & Johnson, Lallemand, Lundbeck, Merck, Ontario Brain Institute, Ontario Mental Health Foundation, Otsuka, Paladin, Pfizer, Queen s University, Sunovion, Takeda, the University Health Network Foundation, and Valeant

4 Rachel Morehouse Daniel J. Müller Abigail Ortiz Sagar V. Parikh Simon Patry Barbara Pavlova, RPsych Norma Lynn Pearson BSc (Pharm) Lena C. Quilty, CPsych Arun V. Ravindran MB,, FRCPC Lakshmi N. Ravindran Paula Ravitz Michael Rosenbluth Jitender Sareen Dalhousie University University of Ottawa Departments of Psychiatry, University of Michigan, Ann Arbor / L Université Laval Dalhousie University Canadian Pharmacists Association University of Manitoba Research funds from Canadian Institutes of Health Research, Canadian Foundations for Innovation, National Alliance for Research in Schizophrenia and Depression, Ontario Mental Health Foundation, National Institutes of Health, and the Consultant to Bristol Myers Squibb, Lundbeck, and Takeda; has had a research contract with Assurex; and has equity in Mensante Speaker and consultant honoraria or research funds from Bristol-Myers Squibb, Canadian Depression Research and Intervention Network, Canadian Foundation for Innovation and the Ministry of Economic Development and Innovation, Canadian Institutes of Health Research, Grand Challenges Canada, Janssen, Lundbeck, Ontario Mental Health Foundation, Pfizer, and Sunovion Honoraria from AstraZeneca, Bristol-Myers Squibb, Canadian Psychiatric Association, Eli Lilly, Lundbeck, Otsuka, Pfizer, and Sunovion

5 Wei-Yi Song Meir Steiner MD, MSc, FRCPC S. Valérie Tourjman Rudolf Uher MB,, FRCPC Ryan J. Van Lieshout Vytas Velyvis, CPsych (Supervised Practice) Fidel Vila-Rodriguez JianLi Wang Lakshmi N. Yatham MBBS, MBA (Exec), FRCPC Department of Psychiatry and Behavioural Neurosciences, McMaster University L Université de Montréal Dalhousie University Department of Psychiatry and Behavioural Neurosciences, McMaster University CBT Associates of Toronto University of Calgary research funds from AstraZeneca, Bristol-Myers Squibb, Canadian Psychiatric Association, Eli Lilly, Forrest Laboratories, Lundbeck, Ortho-Janssen, Pfizer, and Sunovion received research funds from Bristol-Myers Squibb, Eli Lilly, Janssen, Lundbeck, Otsuka, Pfizer, Purdue, Shire, Sunovion, and Valeant Research funds from European Commission Framework 6 Grant funding from Brain Canada and the Canadian Institutes of Health Research Honoraria for ad hoc speaking or received advising/consulting or research funds from AstraZeneca, Bristol-Myers Squibb, Canadian Institutes of Health Research, Canadian Psychiatric Foundation, Eli Lilly, Forest, GlaxoSmithKline, Johnson & Johnson, National Alliance for Research on Schizophrenia and Depression, Novartis, Pfizer, Abbott, Servier, Stanley Foundation, and Wyeth

6 With thanks to: Kimberly Castellano, Sunnybrook Health Sciences Centre Anna Cyriac, University Health Network Tricia da Silva, Centre for Addiction and Mental Health Nicole Edgar, St. Michael s Hospital Trehani Fonseka, University Health Network Lindsay Gabel, Centre for Addiction and Mental Health Paulina Huniewicz Yena Lee, University Health Network Victoria Marshe, Centre for Addiction and Mental Health Marianne McGuire, Providence Care Cindy Woo, University of British Columbia Daysi Zentner, Douglas Mental Health University Institute